189 related articles for article (PubMed ID: 15533930)
1. Targeting of enteropathogenic Escherichia coli EspF to host mitochondria is essential for bacterial pathogenesis: critical role of the 16th leucine residue in EspF.
Nagai T; Abe A; Sasakawa C
J Biol Chem; 2005 Jan; 280(4):2998-3011. PubMed ID: 15533930
[TBL] [Abstract][Full Text] [Related]
2. The EspF N-Terminal of Enterohemorrhagic
Wang X; Du Y; Hua Y; Fu M; Niu C; Zhang B; Zhao W; Zhang Q; Wan C
Front Cell Infect Microbiol; 2017; 7():410. PubMed ID: 28983470
[TBL] [Abstract][Full Text] [Related]
3. EspF is crucial for Citrobacter rodentium-induced tight junction disruption and lethality in immunocompromised animals.
Xia X; Liu Y; Hodgson A; Xu D; Guo W; Yu H; She W; Zhou C; Lan L; Fu K; Vallance BA; Wan F
PLoS Pathog; 2019 Jun; 15(6):e1007898. PubMed ID: 31251784
[TBL] [Abstract][Full Text] [Related]
4. The N-terminal domain of EspF induces host cell apoptosis after infection with enterohaemorrhagic Escherichia coli O157:H7.
Zhao S; Zhou Y; Wang C; Yang Y; Wu X; Wei Y; Zhu L; Zhao W; Zhang Q; Wan C
PLoS One; 2013; 8(1):e55164. PubMed ID: 23372831
[TBL] [Abstract][Full Text] [Related]
5. Enteropathogenic Escherichia coli EspF is targeted to mitochondria and is required to initiate the mitochondrial death pathway.
Nougayrède JP; Donnenberg MS
Cell Microbiol; 2004 Nov; 6(11):1097-111. PubMed ID: 15469437
[TBL] [Abstract][Full Text] [Related]
6. Enteropathogenic E. coli-induced barrier function alteration is not a consequence of host cell apoptosis.
Viswanathan VK; Weflen A; Koutsouris A; Roxas JL; Hecht G
Am J Physiol Gastrointest Liver Physiol; 2008 May; 294(5):G1165-70. PubMed ID: 18356531
[TBL] [Abstract][Full Text] [Related]
7. EPEC effector EspF promotes Crumbs3 endocytosis and disrupts epithelial cell polarity.
Tapia R; Kralicek SE; Hecht GA
Cell Microbiol; 2017 Nov; 19(11):. PubMed ID: 28618099
[TBL] [Abstract][Full Text] [Related]
8. The enteropathogenic Escherichia coli (EPEC) Map effector is imported into the mitochondrial matrix by the TOM/Hsp70 system and alters organelle morphology.
Papatheodorou P; Domańska G; Oxle M; Mathieu J; Selchow O; Kenny B; Rassow J
Cell Microbiol; 2006 Apr; 8(4):677-89. PubMed ID: 16548893
[TBL] [Abstract][Full Text] [Related]
9. The enteropathogenic E. coli effector EspF targets and disrupts the nucleolus by a process regulated by mitochondrial dysfunction.
Dean P; Scott JA; Knox AA; Quitard S; Watkins NJ; Kenny B
PLoS Pathog; 2010 Jun; 6(6):e1000961. PubMed ID: 20585567
[TBL] [Abstract][Full Text] [Related]
10. Comparative analysis of EspF variants in inhibition of Escherichia coli phagocytosis by macrophages and inhibition of E. coli translocation through human- and bovine-derived M cells.
Tahoun A; Siszler G; Spears K; McAteer S; Tree J; Paxton E; Gillespie TL; Martinez-Argudo I; Jepson MA; Shaw DJ; Koegl M; Haas J; Gally DL; Mahajan A
Infect Immun; 2011 Nov; 79(11):4716-29. PubMed ID: 21875965
[TBL] [Abstract][Full Text] [Related]
11. Enteropathogenic Escherichia coli effector EspF interacts with host protein Abcf2.
Nougayrède JP; Foster GH; Donnenberg MS
Cell Microbiol; 2007 Mar; 9(3):680-93. PubMed ID: 17064289
[TBL] [Abstract][Full Text] [Related]
12. The EspF effector, a bacterial pathogen's Swiss army knife.
Holmes A; Mühlen S; Roe AJ; Dean P
Infect Immun; 2010 Nov; 78(11):4445-53. PubMed ID: 20679436
[TBL] [Abstract][Full Text] [Related]
13. Enteropathogenic Escherichia coli dynamically regulates EGFR signaling in intestinal epithelial cells.
Roxas JL; Ryan K; Vedantam G; Viswanathan VK
Am J Physiol Gastrointest Liver Physiol; 2014 Aug; 307(3):G374-80. PubMed ID: 24904077
[TBL] [Abstract][Full Text] [Related]
14. Translocated EspF protein from enteropathogenic Escherichia coli disrupts host intestinal barrier function.
McNamara BP; Koutsouris A; O'Connell CB; Nougayréde JP; Donnenberg MS; Hecht G
J Clin Invest; 2001 Mar; 107(5):621-9. PubMed ID: 11238563
[TBL] [Abstract][Full Text] [Related]
15. Enteropathogenic E. coli disrupts tight junction barrier function and structure in vivo.
Shifflett DE; Clayburgh DR; Koutsouris A; Turner JR; Hecht GA
Lab Invest; 2005 Oct; 85(10):1308-24. PubMed ID: 16127426
[TBL] [Abstract][Full Text] [Related]
16. EspF Interacts with nucleation-promoting factors to recruit junctional proteins into pedestals for pedestal maturation and disruption of paracellular permeability.
Peralta-Ramírez J; Hernandez JM; Manning-Cela R; Luna-Muñoz J; Garcia-Tovar C; Nougayréde JP; Oswald E; Navarro-Garcia F
Infect Immun; 2008 Sep; 76(9):3854-68. PubMed ID: 18559425
[TBL] [Abstract][Full Text] [Related]
17. The type III effector EspF coordinates membrane trafficking by the spatiotemporal activation of two eukaryotic signaling pathways.
Alto NM; Weflen AW; Rardin MJ; Yarar D; Lazar CS; Tonikian R; Koller A; Taylor SS; Boone C; Sidhu SS; Schmid SL; Hecht GA; Dixon JE
J Cell Biol; 2007 Sep; 178(7):1265-78. PubMed ID: 17893247
[TBL] [Abstract][Full Text] [Related]
18. Intestinal barrier dysfunction by enteropathogenic Escherichia coli is mediated by two effector molecules and a bacterial surface protein.
Dean P; Kenny B
Mol Microbiol; 2004 Nov; 54(3):665-75. PubMed ID: 15491358
[TBL] [Abstract][Full Text] [Related]
19. The enteropathogenic Escherichia coli EspF effector molecule inhibits PI-3 kinase-mediated uptake independently of mitochondrial targeting.
Quitard S; Dean P; Maresca M; Kenny B
Cell Microbiol; 2006 Jun; 8(6):972-81. PubMed ID: 16681838
[TBL] [Abstract][Full Text] [Related]
20. Repetitive N-WASP-binding elements of the enterohemorrhagic Escherichia coli effector EspF(U) synergistically activate actin assembly.
Campellone KG; Cheng HC; Robbins D; Siripala AD; McGhie EJ; Hayward RD; Welch MD; Rosen MK; Koronakis V; Leong JM
PLoS Pathog; 2008 Oct; 4(10):e1000191. PubMed ID: 18974829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
